- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Clinical and Developmental Immunology
Volume 2013 (2013), Article ID 296031, 7 pages
Dexamethasone Preconditioning Improves the Response of Collagen-Induced Arthritis to Treatment with Short-Term Lipopolysaccharide-Stimulated Collagen-Loaded Dendritic Cells
1Immune Regulation and Tolerance Research Group, Programa Disciplinario de Inmunología, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Avenida Independencia 1027, Santiago, Chile
2Millennium Institute on Immunology and Immunotherapy-Chile (P09-016-F), Santiago, Chile
Received 27 January 2013; Revised 7 May 2013; Accepted 13 May 2013
Academic Editor: Beatrice Gaugler
Copyright © 2013 Corina Peña et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- R. M. Steinman, D. Hawiger, and M. C. Nussenzweig, “Tolerogenic dendritic cells,” Annual Review of Immunology, vol. 21, pp. 685–711, 2003.
- K. Steinbrink, M. Wölfl, H. Jonuleit, J. Knop, and A. H. Enk, “Induction of tolerance by IL-10-treated dendritic cells,” The Journal of Immunology, vol. 159, no. 10, pp. 4772–4780, 1997.
- A. E. Anderson, B. L. Sayers, M. A. Haniffa et al., “Differential regulation of naïve and memory CD4+ T cells by alternatively activated dendritic cells,” Journal of Leukocyte Biology, vol. 84, no. 1, pp. 124–133, 2008.
- A. Chorny, E. Gonzalez-Rey, A. Fernandez-Martin, D. Pozo, D. Ganea, and M. Delgado, “Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 38, pp. 13562–13567, 2005.
- M. Menges, S. Rößner, C. Voigtländer et al., “Repetitive injections of dendritic cells matured with tumor necrosis factor α induce antigen-specific protection of mice from autoimmunity,” Journal of Experimental Medicine, vol. 195, no. 1, pp. 15–21, 2002.
- L. Salazar, O. Aravena, P. Abello et al., “Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells,” Annals of the Rheumatic Diseases, vol. 67, no. 9, pp. 1235–1241, 2008.
- L. M. van Duivenvoorde, W. G. H. Han, A. M. Bakker et al., “Immunomodulatory dendritic cells inhibit Th1 responses and arthritis via different mechanisms,” The Journal of Immunology, vol. 179, no. 3, pp. 1506–1515, 2007.
- D. Garate, N. Rojas-Colonelli, C. Pena, et al., “Blocking of p38 and transforming growth factor beta receptor pathways impairs the ability of tolerogenic dendritic cells to suppress murine arthritis,” Arthritis & Rheumatism, vol. 65, no. 1, pp. 120–129, 2013.
- T. Hügle and J. M. van Laar, “Stem cell transplantation for rheumatic autoimmune diseases,” Arthritis Research and Therapy, vol. 10, no. 5, article 217, 2008.
- F. Buttgereit, K. G. Saag, M. Cutolo, J. A. P. da Silva, and J. W. J. Bijlsma, “The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis,” Scandinavian Journal of Rheumatology, vol. 34, no. 1, pp. 14–21, 2005.
- T. Wilckens and R. de Rijk, “Glucocorticoids and immune function: unknown dimensions and new frontiers,” Immunology Today, vol. 18, no. 9, pp. 418–424, 1997.
- X. Chen, T. Murakami, J. J. Oppenheim, and O. M. Z. Howard, “Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death,” European Journal of Immunology, vol. 34, no. 3, pp. 859–869, 2004.
- C. Karagiannidis, M. Akdis, P. Holopainen et al., “Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma,” The Journal of Allergy and Clinical Immunology, vol. 114, no. 6, pp. 1425–1433, 2004.
- C. Prado, J. Gómez, P. López, B. de Paz, C. Gutiérrez, and A. Suárez, “Dexamethasone upregulates FOXP3 expression without increasing regulatory activity,” Immunobiology, vol. 216, no. 3, pp. 386–392, 2011.
- F. Hua, L. Ji, Y. Zhan, et al., “Pulsed high-dose dexamethasone improves interleukin 10 secretion by CD5+ B cells in patients with primary immune thrombocytopenia,” Journal of Clinical Immunology, vol. 32, no. . 6, pp. 1233–1242, 2012.
- M. H. Blotta, R. H. DeKruyff, and D. T. Umetsu, “Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes,” The Journal of Immunology, vol. 158, no. 12, pp. 5589–5595, 1997.
- E. C. de Jong, P. L. Vieira, P. Kalinski, and M. L. Kapsenberg, “Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3,” Journal of Leukocyte Biology, vol. 66, no. 2, pp. 201–204, 1999.
- J. Pan, D. Ju, Q. Wang et al., “Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway,” Immunology Letters, vol. 76, no. 3, pp. 153–161, 2001.
- R. Flierman, H. J. Witteveen, E. I. H. van der Voort et al., “Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and major histocompatibility complex-mismatched allogeneic bone marrow transplantation,” Blood, vol. 105, no. 7, pp. 2991–2994, 2005.
- L. E. Harrington, P. R. Mangan, and C. T. Weaver, “Expanding the effector CD4 T-cell repertoire: the Th17 lineage,” Current Opinion in Immunology, vol. 18, no. 3, pp. 349–356, 2006.
- A. E. Anderson, D. J. Swan, B. L. Sayers et al., “LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells,” Journal of Leukocyte Biology, vol. 85, no. 2, pp. 243–250, 2009.
- M. Bax, S. J. van Vliet, M. Litjens, J. J. García-Vallejo, and Y. van Kooyk, “Interaction of polysialic acid with CCL21 regulates the migratory capacity of human dendritic cells,” PLoS ONE, vol. 4, no. 9, Article ID e6987, 2009.